<description>
        &lt;p&gt;On this week’s Tech Nation, Moira speaks with Dr. Cory Nicholas, Co-Founder and CEO of Neurona Therapeutics, about a breakthrough in neuroscience that leads to a new therapy showing lasting success in epilepsy. There's potential for Parkinson's, Alzheimer's, PTSD, and more.&lt;/p&gt;
      </description>

On this week’s Tech Nation, Moira speaks with Dr. Cory Nicholas, Co-Founder and CEO of Neurona Th...

On this week’s Tech Nation, Moira speaks with Dr. Cory Nicholas, Co-Founder and CEO of Neurona Therapeutics, about a breakthrough in neuroscience that leads to a new therapy showing lasting success in epilepsy. There's potential for Parkinson's, Alzheimer's, PTSD, and more.

Episode 679: Episode 26-22 A Leap Forward in Neuroscience

<description>
        &lt;p&gt;On this week’s Tech Nation, Moira speaks with Pulitzer Prize-winning journalist Gary Rivlin about his new book, “AI Valley: Microsoft, Google, and the Trillion-Dollar Race to Cash In on Artificial Intelligence”, exposing the big names and deeper stories behind the modern AI race. Then, Ossium Health CEO Kevin Caldwell shares how cryo-banked bone marrow may one day mean no one has to wait for a living match.&lt;/p&gt;
      </description>

On this week’s Tech Nation, Moira speaks with Pulitzer Prize-winning journalist Gary Rivlin about...

On this week’s Tech Nation, Moira speaks with Pulitzer Prize-winning journalist Gary Rivlin about his new book, “AI Valley: Microsoft, Google, and the Trillion-Dollar Race to Cash In on Artificial Intelligence”, exposing the big names and deeper stories behind the modern AI race. Then, Ossium Health CEO Kevin Caldwell shares how cryo-banked bone marrow may one day mean no one has to wait for a living match.

Episode 678: Episode 26-21 Big Tech’s AI Grab…

<description>
        &lt;p&gt;On this week’s Tech Nation, with constant interruptions from attention-grabbing tech, how setting constraints for yourself can spark creativity and innovation…&lt;br&gt;Then, a biotech company with two new drug approvals in two years. And…could it be possible to have hospital care...at home?&lt;/p&gt;
      </description>

On this week’s Tech Nation, with constant interruptions from attention-grabbing tech, how setting...

On this week’s Tech Nation, with constant interruptions from attention-grabbing tech, how setting constraints for yourself can spark creativity and innovation…Then, a biotech company with two new drug approvals in two years. And…could it be possible to have hospital care...at home?

Episode 677: Episode 26-20 Thinking “Inside the Box”???

<description>
        &lt;p&gt;On this week’s Tech Nation, what is ransomware? And is it still going strong?&lt;br&gt;Moira speaks with King’s College London Professor of Political Economy, Anja Shortland, about her book “Dark Screens: Hackers and Heroes in the Shadowy World of Ransomware.” Then, Dr. Jonas Hannestad &amp;amp; Dr. Joanne Taylor discuss how Gain Therapeutics is taking a new approach to treating Parkinson’s by targeting the disease itself. And, Dr. Daniel Kraft shares how he thinks the future of healthcare could be more like a Waymo&lt;/p&gt;
      </description>

On this week’s Tech Nation, what is ransomware? And is it still going strong?Moira speaks with Ki...

On this week’s Tech Nation, what is ransomware? And is it still going strong?Moira speaks with King’s College London Professor of Political Economy, Anja Shortland, about her book “Dark Screens: Hackers and Heroes in the Shadowy World of Ransomware.” Then, Dr. Jonas Hannestad &amp; Dr. Joanne Taylor discuss how Gain Therapeutics is taking a new approach to treating Parkinson’s by targeting the disease itself. And, Dr. Daniel Kraft shares how he thinks the future of healthcare could be more like a Waymo

Episode 676: Episode 26-19 Ransomware: Behind the Screens

<description>
        &lt;p&gt;On this week’s Tech Nation, we celebrate the 50th anniversary of the first biotech company to go public, Genentech. Moira speaks with CEO Ashley Magargee about the company’s journey since its founding 50 years ago, and where they’re going next. Then, we remember the life of the late Dr. Craig Venter, whose efforts catalysed the race to decode the first human genome.&lt;/p&gt;
      </description>

On this week’s Tech Nation, we celebrate the 50th anniversary of the first biotech company to go ...

On this week’s Tech Nation, we celebrate the 50th anniversary of the first biotech company to go public, Genentech. Moira speaks with CEO Ashley Magargee about the company’s journey since its founding 50 years ago, and where they’re going next. Then, we remember the life of the late Dr. Craig Venter, whose efforts catalysed the race to decode the first human genome.

Episode 675: Episode 26-18 Pioneers in Biotech


      <p>TechNation Radio hosted by Dr Moira Gunn</p>
    

TechNation Radio Podcast

Details

Recent Episodes